AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Cancer Biology & Medicine Article
PDF (457.4 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Editorial | Open Access

Using triple radio-immunotherapy to overcome cancer immunotherapy resistance

Zengfu Zhang1,*, Xiaodong Zhang2,*, Dawei Chen1,2 ( )
Department of Radiation Oncology, Shandong University Cancer Center, Jinan 250117, China
Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China

*These authors contributed equally to this work.

Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Cancer Biology & Medicine
Volume 20 Issue 11,
November 2023
Pages 788-794
DOI: 10.20892/j.issn.2095-3941.2023.0268

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Zhang Z, Zhang X, Chen D. Using triple radio-immunotherapy to overcome cancer immunotherapy resistance. Cancer Biology & Medicine, 2023, 20(11): 788-794. https://doi.org/10.20892/j.issn.2095-3941.2023.0268

370

Views

42

Downloads

2

Crossref

4

Web of Science

4

Scopus
Received: 20 July 2023
Accepted: 16 October 2023
Published: 16 November 2023
©2023 Cancer Biology & Medicine.

Creative Commons Attribution-NonCommercial 4.0 International License